| Jan 31,
2022 | Jan 31,
2023 | Jan 31,
2024 | Jan 31,
2025 |
|---|
| Net loss | -526 | -328 | -90 | -74 |
|---|
| Depreciation and amortization | 15 | 19 | 23 | 17 |
|---|
| Capitalized Contract Cost, Amortization | 39 | 60 | 75 | 92 |
|---|
| Net accretion on marketable securities | -2 | 2 | 28 | 32 |
|---|
| Stock-based compensation expense | 516 | 370 | 372 | 358 |
|---|
| Noncash Contribution Expense | - | 6 | 4 | 7 |
|---|
| Non-cash operating lease expense | 9 | 12 | 13 | 16 |
|---|
| Asset Impairment Charges | - | 3 | - | - |
|---|
| Deferred Income Tax Expense (Benefit) | -6 | 1 | 1 | -20 |
|---|
| Other non-cash credits, net | -2 | 2 | 4 | 2 |
|---|
| Accounts receivable | 86 | 124 | 64 | 22 |
|---|
| Contract assets | 44 | 0 | 15 | 4 |
|---|
| Deferred contract acquisition costs | 130 | 119 | 119 | 89 |
|---|
| Prepaid expenses and other assets | 15 | 60 | -4 | -7 |
|---|
| Accounts payable | 4 | -2 | -5 | 28 |
|---|
| Accrued expenses and other liabilities | 46 | -15 | 12 | 9 |
|---|
| Accrued compensation and employee benefits | 24 | 15 | -4 | -23 |
|---|
| Operating lease liabilities, net | -9 | -3 | -14 | -16 |
|---|
| Deferred revenue | 105 | 161 | 137 | 68 |
|---|
| Net cash provided by (used in) operating activities | -55 | -10 | 299 | 321 |
|---|
| Purchases of marketable securities | 213 | 388 | 1,486 | 1,470 |
|---|
| Maturities of marketable securities | 108 | 151 | 1,051 | 1,476 |
|---|
| Purchases of property and equipment | 9 | 24 | 7 | 15 |
|---|
| Payments related to business acquisitions, net of cash acquired | 5 | 30 | - | - |
|---|
| Purchases of investments | 2 | - | - | 36 |
|---|
| Other investing, net | - | -1 | -3 | - |
|---|
| Net cash used in investing activities | -35 | -289 | -440 | -46 |
|---|
| Repurchases of Class A common stock | - | - | 103 | 391 |
|---|
| Proceeds from Stock Options Exercised | 12 | 8 | 7 | 8 |
|---|
| Payments of tax withholdings on net settlement of equity awards | 10 | 73 | 112 | 78 |
|---|
| Net receipts (payments) of tax withholdings on sell-to-cover equity award transactions | - | -9 | -1 | 0 |
|---|
| Proceeds from Stock Plans | 19 | 15 | 18 | 16 |
|---|
| Payment of deferred consideration related to business acquisition | - | - | 6 | 6 |
|---|
| Repurchase of unvested early exercised stock options | - | 1 | - | - |
|---|
| Net cash used in financing activities | 1,470 | -61 | -197 | -451 |
|---|
| Effect of exchange rate changes | - | - | -3 | -7 |
|---|
| Net decrease in cash, cash equivalents, and restricted cash | 1,398 | -367 | -340 | -182 |
|---|
| Cash paid for interest | 1 | 1 | 1 | 0 |
|---|
| Income Taxes Paid, Net | 8 | 21 | 11 | 17 |
|---|
| Stock Issued | 30 | 3 | - | - |
|---|
| Loan notes issued in connection with business acquisitions | - | 11 | - | - |
|---|
| Reduction in accrued expenses and other liabilities for vesting of early exercised stock options | 3 | 1 | 0 | 0 |
|---|
| Tax Withholdings On Net Settlement Of Restricted Stock Units Accrued And Unpaid | 0 | 2 | 3 | 5 |
|---|
| Capital Expenditures Incurred but Not yet Paid | 2 | 1 | 1 | 3 |
|---|